The Cancer Research Institute supports innovative research in the fields of immunology and tumor immunology along the entire spectrum of discovery and at every stage of scientific career development.
CRI funds postdoctoral fellowships, including tracks to promote diversity in the field as well as proficiencies in immuno-informatics, grants to support translational research and technology development, and grants of upwards of a million dollars or more to fund early-stage clinical trials of novel immunotherapy combinations as well as support mid-career investigators carrying out high-risk / high-reward research with the potential to make the next great leap in cancer immunotherapy.
Postdoctoral Fellowship
The CRI Irvington Postdoctoral Fellowship Program furthers career development and supports laboratory research for promising young scientists working under the mentorship of leading immunologists.
Application Deadline: March 1; September 1
Postdoctoral Fellowship to Promote Racial Diversity
Supporting Underrepresented Scientists in Immuno-Oncology
The CRI Irvington Postdoctoral Fellowship to Promote Racial Diversity furthers career development and supports laboratory research for promising young scientists who identify as Black or African American, Hispanic or Latino/a American, or American Indian or Alaska Native, working under the mentorship of leading immunologists.
Application Deadline: March 1; September 1
Immuno-Informatics Postdoctoral Fellowship
NEW PROGRAM: The CRI Immuno-Informatics Postdoctoral Fellowship addresses a critical need in cancer immunology for scientists with expertise in both quantitative and biological sciences. The combination of these two areas of research is seen as the next step to fuel the discovery of new immunotherapies.
Application Deadline: March 1; September 1
APPLICATION AND GUIDELINES COMING SOON
Clinic and Laboratory Integration Program (CLIP)
The Clinic and Laboratory Integration Program (CLIP) grants provide catalytic support for the translation of basic laboratory discoveries into novel therapies that can be tested in patients.
LOI Deadline: December 1
Lloyd J. Old STAR Program
The Lloyd J. Old STAR Program provides grants of $1.25 million over 5 years to mid-career scientists. This long-term funding is not tied to a specific research project, but rather aims to provide a degree of flexibility and freedom for investigators to explore outside-the-box and disruptive avenues of research. Candidates selected for this award are expected to be future “stars” in the field of cancer immunology: Scientists TAking Risks.
Application Deadline: January 15
Technology Impact Award
The CRI Technology Impact Award provides seed funding of up to $200,000 to be used over 12-24 months to address the gap between technology development and the clinical application of cancer immunotherapies.
LOI Deadline: November 15
Clinical Innovator
The Clinical Innovator will support novel clinical studies that address areas of high unmet need in cancer and seek mechanistic insights into clinical response with a goal of predictive biomarker discovery. To maximize the impact of each clinical trial, CRI will advise on selected studies in a coordinated effort to optimize clinical trial design and translational studies.